HLS Therapeutics reports positive data from Covid-19 outpatient trial,

HLS Therapeutics has announced that clinical results from the CardioLink-9 Trial showed Vascepa (icosapent ethyl) provided an anti-inflammatory …, HLS Therapeutics has announced that clinical results from the CardioLink-9 Trial showed Vascepa (icosapent ethyl) provided an anti-inflammatory …, Read More

Scroll to Top